Sotorasib
Brand name: Lumakras
Sotorasib comes in 5 pill versions in our database, in 3 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Sotorasib pill images
120 mg 2 pills
- AMG120 Sotorasib 120 mg Yellow, rectangle, 16 mm Used for lung cancer
- No picture yet DIN 02520095 Sotorasib 120 mg Lumakras, Tablet, sold in Canada Used for lung cancer
240 mg 2 pills
- AMG240 Sotorasib 240 mg Yellow, oval, 18 mm Used for lung cancer
- AMG 240 Sotorasib 240 mg Yellow, oval, 18 mm Used for lung cancer
320 mg 1 pill
What is Sotorasib used for?
Sotorasib is used for lung cancer.
Official uses from the US prescribing label
KRAS G12C-mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
LUMAKRAS as a single agent is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
This indication is approved under accelerated approval based on overall response rate (ORR) and duration of response (DOR). Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
KRAS G12C-mutated Metastatic Colorectal Cancer (mCRC)
LUMAKRAS, in combination with panitumumab, is indicated for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer (mCRC), as determined by an FDA-approved test, who have received prior fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy.
From the FDA-approved label on DailyMed (published Jan 30, 2025).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.